Related references
Note: Only part of the references are listed.Rapid Anxiolytic Effects of RS67333, a Serotonin Type 4 Receptor Agonist, and Diazepam, a Benzodiazepine, Are Mediated by Projections From the Prefrontal Cortex to the Dorsal Raphe Nucleus
Charlene Faye et al.
BIOLOGICAL PSYCHIATRY (2020)
Biological Signatures of Alzheimer's Disease
Poornima Sharma et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
Md. Sahab Uddin et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease
Md Sahab Uddin et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Neuron-glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics
Abdallah Mohammad Ibrahim et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2020)
TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology
Md. Sahab Uddin et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease
Abdullah Al Mamun et al.
NEUROTOXICITY RESEARCH (2020)
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Md Sahab Uddin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
Abdullah Al Mamun et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration
Md Sahab Uddin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Seetha Harilal et al.
BRAIN RESEARCH BULLETIN (2020)
Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease
Md Sahab Uddin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease
Md Sahab Uddin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease
Md. Sahab Uddin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer's Disease
Md Sahab Uddin et al.
MOLECULAR NEUROBIOLOGY (2020)
Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease
Md Sahab Uddin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Toxic tau: structural origins of tau aggregation in Alzheimer's disease
Abdullah Al Mamun et al.
NEURAL REGENERATION RESEARCH (2020)
Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh
Md Sahab Uddin et al.
PSYCHOGERIATRICS (2019)
Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease
Martina Kaniakova et al.
CURRENT ALZHEIMER RESEARCH (2019)
Donepezil plus chromone plus melatonin hybrids as promising agents for Alzheimer's disease therapy
Irene Pachon-Angona et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
Stefano Alcaro et al.
FRONTIERS IN CHEMISTRY (2019)
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
Tao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Natural Products in Alzheimer's Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
Solomon Habtemariam
MOLECULES (2019)
Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches
Juan F. Gonzalez et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology
Md Farhad Hossain et al.
MOLECULAR NEUROBIOLOGY (2019)
Controlled lontophoretic Delivery in Vitro and in Vivo of ARN14140-A Multitarget Compound for Alzheimer's Disease
Mayank Singhal et al.
MOLECULAR PHARMACEUTICS (2019)
Management of oxidative stress and other pathologies in Alzheimer's disease
Miriama Simunkova et al.
ARCHIVES OF TOXICOLOGY (2019)
Aggregation States of Aβ1-40, Aβ1-42 and Aβp3-42 Amyloid Beta Peptides: A SANS Study
Giulia Festa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Low-dose ladostigil for mild cognitive impairment A phase 2 placebo-controlled clinical trial
Lon S. Schneider et al.
NEUROLOGY (2019)
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
A novel class of multitarget anti-Alzheimer benzohomoadamantane- chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors
F. Javier Perez-Areales et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
Rajesh Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology
Md. Sahab Uddin et al.
MOLECULAR NEUROBIOLOGY (2019)
Alzheimer's Disease, the One-Molecule, One-Target Paradigm, and the Multitarget Directed Ligand Approach
Maria Jesus Oset-Gasque et al.
ACS CHEMICAL NEUROSCIENCE (2018)
A molecular approach in drug development for Alzheimer's disease
Snezana Agatonovic-Kustrin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Development of tacrine-bifendate conjugates with improved cholinesterase inhibitory and pro-cognitive efficacy and reduced hepatotoxicity
Juan Cen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Neuroinflammation Signaling Modulated by ASS234, a Multitarget Small Molecule for Alzheimer's Disease Therapy
Javier del Pino et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review
Jinghong Liang et al.
CLINICAL INTERVENTIONS IN AGING (2018)
Donepezil for dementia due to Alzheimer's disease
Jacqueline S. Birks et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Spectrum of Disease and Prescription Pattern for Outpatients with Neurological Disorders: An Empirical Pilot Study in Bangladesh
Md. Sahab Uddin et al.
ANNALS OF NEUROSCIENCES (2018)
New azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyryicholinesterase showing protective effects against NMDA-induced neurotoxicity
Modesto de Candia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Cholinergic System Modulates Memory and Hippocampal Plasticity via its interactions with Non-Neuronal Cells
Sara V. Maurer et al.
FRONTIERS IN IMMUNOLOGY (2017)
Alzheimer's Disease: A Systemic Review of Substantial Therapeutie Targets and the Leading Multi-functional Molecules
Tarana Umar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment
Sergey O. Bachurin et al.
SCIENTIFIC REPORTS (2017)
Novel Conjugates of Tacrine with 1,2,4,-Thiadiazole as Highly Effective Cholinesterase Inhibitors, Blockers of NMDA Receptors, and Antioxidants
G. F. Makhaeva et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2017)
Autophagic Dysfunction in Type 2 Diabetes Mellitus: Pathophysiology and Therapeutic Implications
Tanjir Islam et al.
JOURNAL OF DIABETES & METABOLISM (2017)
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Orly Weinreb et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's Disease
Angelo M. Reggiani et al.
SCIENTIFIC REPORTS (2016)
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
Hassan Al-Ali et al.
ACS CHEMICAL BIOLOGY (2015)
Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties
Sai-Sai Xie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride
Christophe Rochais et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
Galina F. Makhaeva et al.
SCIENTIFIC REPORTS (2015)
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
Hiroto Takahashi et al.
SCIENTIFIC REPORTS (2015)
Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study
Kosuke Matsuzono et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease
Gerard Esteban et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease
Angel Agis-Torres et al.
CURRENT NEUROPHARMACOLOGY (2014)
Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia
Anna Stasiak et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease
Supatra Thiratmatrakul et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chromones as a privileged scaffold in drug discovery: A review
Rangappa S. Keri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Riqiang Yan et al.
LANCET NEUROLOGY (2014)
Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events
Kiran Bhaskar et al.
NEUROBIOLOGY OF DISEASE (2014)
Multi-target Design Strategies in the Context of Alzheimer's Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces
Michela Rosini et al.
NEUROCHEMICAL RESEARCH (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Cedric Lecoutey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
From Single Target to Multitarget/Network Therapeutics in Alzheimer's Therapy
Hailin Zheng et al.
PHARMACEUTICALS (2014)
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase
Marco Catto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity
Fei Mao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The Bivalent Ligand Approach as a Tool for Improving the in vitro Anti-Alzheimer Multitarget Profile of Dimebon
Michela Rosini et al.
CHEMMEDCHEM (2013)
Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
Zaira Esposito et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro
Irene Bolea et al.
CURRENT ALZHEIMER RESEARCH (2013)
Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno[3′,4′:5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase
Mehdi Khoobi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design, synthesis and evaluation of novel tacrine coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease
Sai-Sai Xie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model
Peng Jin et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight Aβ Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers
Claudia P. Figueiredo et al.
JOURNAL OF NEUROSCIENCE (2013)
Blockade of Tau Hyperphosphorylation and Aβ1-42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer's Disease
Valentine Lahmy et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Elevated amyloid-beta plaque deposition in dietary selenium-deficient Tg2576 transgenic mice
Mamoru Haratake et al.
METALLOMICS (2013)
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
Chris G. Parsons et al.
NEUROTOXICITY RESEARCH (2013)
Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
Valeria Capurro et al.
PLOS ONE (2013)
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Veda Prachayasittikul et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Early administration of RS67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease
Patrizia Giannoni et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Current and future treatments for Alzheimer's disease
Konstantina G. Yiannopoulou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Antioxidants for Alzheimer Disease A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures
Douglas R. Galasko et al.
ARCHIVES OF NEUROLOGY (2012)
AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease
Satoshi Mizuno et al.
BMC SYSTEMS BIOLOGY (2012)
From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease
Hailin Zheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases
Caries Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer's Disease
Elena Simoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
O. Peters et al.
JOURNAL OF NUTRITION HEALTH & AGING (2012)
Synergistic Effects of Galantamine and Memantine in Attenuating Scopolamine-Induced Amnesia in Mice
Perrine Busquet et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo
Rongbiao Pi et al.
PLOS ONE (2012)
Synapses and Alzheimer's Disease
Morgan Sheng et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias
Taim Muayqil et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2012)
The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine
Csaba Nyakas et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease
Michela Rosini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Use of memantine for the treatment of dementia
Daphne Lo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder
Rukhsana Sultana et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer's Disease
Irene Bolea et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Iron and Neurodegeneration in Multiple Sclerosis
Michael Khalil et al.
MULTIPLE SCLEROSIS INTERNATIONAL (2011)
Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238
Stefano Rizzo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Novel Huprine Derivatives with Inhibitory Activity toward β-Amyloid Aggregation and Formation as Disease-Modifying Anti-Alzheimer Drug Candidates
Elisabet Viayna et al.
CHEMMEDCHEM (2010)
Antioxidant approaches for the treatment of Alzheimer's disease
Hyun Pil Lee et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Amyloid-beta as a Modulator of Synaptic Plasticity
Mordhwaj S. Parihar et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Novel Tacrine-8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties
Maria Isabel Fernandez-Bachiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
Orly Weinreb et al.
PROGRESS IN NEUROBIOLOGY (2010)
PHARMACOLOGY The Puzzling Rise and Fall of a Dark-Horse Alzheimer's Drug
Greg Miller
SCIENCE (2010)
Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors
Michela Guglielmotto et al.
FRONTIERS IN AGING NEUROSCIENCE (2010)
Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease
Mitsugu Fukuda et al.
BIOMEDICAL RESEARCH-TOKYO (2009)
Design, synthesis and evaluation of novel 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-2-indenyl-3,4-substituted phenyl methanone analogues
Mohamed Ashraf Ali et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Site-Activated Multifunctional Chelator with Acetylcholinesterase and Neuroprotective-Neurorestorative Moieties for Alzheimer's Therapy
Hailin Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Toward a Rational Design of Multitarget-Directed Antioxidants: Merging Memoquin and Lipoic Acid Molecular Frameworks
Maria Laura Bolognesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The Novel Cholinesterase-Monoamine Oxidase Inhibitor and Antioxidant, Ladostigil, Confers Neuroprotection in Neuroblastoma Cells and Aged Rats
Orit Bar-Am et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
Memoquin: A Multi-Target-Directed Ligand as an Innovative Therapeutic Opportunity for Alzheimer's Disease
Maria Laura Bolognesi et al.
NEUROTHERAPEUTICS (2009)
Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy Lights and Shadows
Domenico Pratico
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity
Orly Weinreb et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Memantine protects rat cortical cultured neurons against β-amyloid-induced toxicity by attenuating tau phosphorylation
M. S. Song et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease
Karl Herholz
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Elliott J Mufson et al.
Expert Review of Neurotherapeutics (2008)
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
Tamar Amit et al.
FASEB JOURNAL (2008)
Nucleic acid oxidation in Alzheimer disease
Paula I. Morelra et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation
Pelayo Camps et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer's disease:: A promising direction for the multi-target-directed ligands gold rush
Michela Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Protective effects of ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat
K. Yamagata et al.
NEUROSCIENCE (2008)
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide
Takaaki Hayashi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Three histidine residues of amyloid-β peptide control the redox activity of copper and iron
M. Nakamura et al.
BIOCHEMISTRY (2007)
High content screen microscopy analysis of Ap1-42-induced neurite outgrowth reduction in rat primary cortical neurons:: Neuroprotective effects of α7 neuronal nicotinic acetylcholine receptor ligands
Min Hu et al.
BRAIN RESEARCH (2007)
Alzheimer disease, the two-hit hypothesis: An update
Xiongwei Zhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease
Hugo Geerts et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Simultaneous release of glutamate and acetylcholine from single magnocellular cholinergic basal forebrain neurons
TGJ Allen et al.
JOURNAL OF NEUROSCIENCE (2006)
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases:: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition
H Zheng et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion
S Gal et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
R Bullock et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Trolox and 17β-estradiol protect against amyloid β-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway
RA Quintanilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site
G Akk et al.
JOURNAL OF NEUROSCIENCE (2005)
Rational approach to discover multipotent anti-Alzheimer drugs
M Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Monoamine oxidases: Certainties and uncertainties
KF Tipton et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Structure and mechanism of monoamine oxidase
DE Edmondson et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents
DK Lahiri et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons:: Ca2+ signals and neurotransmitter release.
FA Dajas-Bailador et al.
MOLECULAR PHARMACOLOGY (2003)
3-(4-{[benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation:: A dual function lead for Alzheimer's disease therapy
L Piazzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Cost of illness of Alzheimer's disease: How useful are current estimates?
BS Bloom et al.
GERONTOLOGIST (2003)
The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition
LB Willard et al.
EXPERIMENTAL BRAIN RESEARCH (2000)
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
YB Choi et al.
NATURE NEUROSCIENCE (2000)
Share Paper
